微孔退火颗粒水凝胶用于声带长期填充的研究
本研究开发了一种新型永久性可注射生物材料——微孔退火颗粒(MAP)水凝胶,并在两种动物模型中评估其性能。32只新西兰白兔接受单侧注射MAP、生理盐水或透明质酸,结果显示MAP凝胶在6个月内保持体积无迁移,免疫原性极低,组织整合和血管化良好,且未损害黏膜波,有望成为声带功能不全的新疗法。
要点
- MAP水凝胶可匹配声带肌硬度,注射后6个月保持体积无迁移。
- 组织学显示MAP凝胶免疫原性极低,并促进组织整合和血管化。
- 所有注射材料均未损害黏膜波,MAP凝胶保留生物力学功能。
核心结论
- MAP凝胶是一种不可吸收的生物刺激性可注射植入物,相比现有植入物具有更优的组织整合、硬度匹配和持久性。
研究设计与样本
- 动物模型研究,使用32只新西兰白兔,单侧注射MAP(n=16)、生理盐水(n=8)或透明质酸(n=8),在0天、6周、4个月和6个月终点评估。
主要发现
- 组织学分析证实MAP凝胶组在植入后6个月保持体积且无迁移。
- 免疫染色显示植入物生命周期内免疫原性极低至不存在。
- 免疫荧光染色观察到MAP凝胶组内广泛的组织整合和血管化。
- 任何注射材料均未损害黏膜波,包括MAP凝胶填充。
临床怎么用
- MAP凝胶可能作为治疗声门功能不全的新型注射填充材料,但需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: The purpose of this study was to develop and provide evidence of a novel permanent injectable biomaterial for vocal fold augmentation with the potential to treat glottic incompetence by evaluating its performance in two animal models. STUDY DESIGN: Animal model. METHODS: Microporous annealed particle (MAP) hydrogel was fabricated using a water-in-oil emulsion method and synthetically tuned to match the stiffness modulus of native vocalis muscle. Thirty-two New Zealand White rabbits were administered unilateral injections of MAP (n = 16), saline (n = 8), and the clinical standard hyaluronic acid (Restylane-L) (n = 8), and evaluated at day 0, and 6-week, 4-month, and 6-month endpoints. Induced vocal fold vibration was recorded with a high-speed camera prior to euthanization, with glottic closure and mucosal wave characteristics assessed both quantitatively and qualitatively by an experienced voice clinician. Histologic analysis was performed to assess scaffold permanence, immunogenicity, and vascularization within the scaffold. RESULTS: Histologic analysis confirmed the MAP gel treatment group maintained its volume without migration for 6 months postimplantation. Immune staining showed minimal to nonexistent immunogenicity over the course of the implant lifetime. Extensive tissue integration and vascularization was observed histologically within the MAP gel group by immunofluorescence staining. Mucosal wave was not impaired by any of the injected materials, including the MAP gel augmentation. CONCLUSIONS: MAP gel is a nonresorbable biostimulatory injectable implant that provides superior tissue integration, stiffness matching, and permanence compared to current injectable implants, with retained biomechanical function, suggesting its potential as a new therapeutic for glottic incompetence. LEVEL OF EVIDENCE: NA Laryngoscope, 130:2432-2441, 2020.
引用
- Pruett L, Koehn H, Martz T, et al. Development of a microporous annealed particle hydrogel for long-term vocal fold augmentation. Laryngoscope. 2019. PMID: 31821567. doi:10.1002/lary.28442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。